Mitotic MELK-eIF4B signaling controls protein synthesis and tumor cell survival.
Proceedings of the National Academy of Sciences of the United States of America.
Times cited: 28
Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin.
Science Translational Medicine.
Times cited: 40